The Opportunity
The heart of insitro’s strategy is the development of novel, innovative methods in machine learning and high-throughput biology that address key bottlenecks in the drug development pipeline. To accomplish this, we are putting together a team of life scientists with expertise in cellular and biochemical assays. The Associate Scientist II/III, Liver Cell Biologist will be responsible for the development and execution of mid/high throughput biochemical/cellular assays and mechanistic experimentation to advance early drug discovery projects. The candidate will work closely with a team of multidisciplinary scientists to enable key assays/models and studies to advance a diverse portfolio of small molecules targeting neurological and metabolic disorders. We value clear communication, creative-thinking, collaboration, and meticulous scientific exploration. If you are a highly motivated individual and teammate with a strong desire to impact drug discovery across multiple therapeutic areas, we invite you to consider joining our team.
Your primary duties will be to:
- Develop, optimize, and perform cellular assays at to support the Metabolic Diseases therapeutic area
- Culture immortalized, primary (e.g. hepatocytes) and iPSC-derived cells
- Maintain accurate documentation of experiments in electronic lab notebook (ELN) and follow all laboratory training and safety requirements
- Evaluate and implement new enabling technologies and methodologies
- Collaborate with colleagues on multi-disciplinary project teams to provide scientific/technical contributions and deliver project goals
You will be joining a biotech startup with long-term stability due to significant funding, but yet is very much in formation. A lot can change in this early and exciting phase, providing many opportunities for significant impact. You will work closely with a versatile team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and outcomes. Join us, and help make a difference to patients!
About You
- BS/MS in Biochemistry, Cell Biology, Pharmacology or a relevant scientific field, with a minimum of three (3) years of drug discovery experience in a biotech/pharmaceutical setting
- Experience with the development and execution cellular assays, using a wide range of experimental methods and detection technologies including advanced microscopy, ELISA, Alphalisa techniques
- Demonstrated ability to work in cross-functional teams to advance drug discovery, with excellent organization and communication skills
- Hands on experience with various automated liquid handling instrumentation is preferred
- Experience in iPSC differentiation and proliferation assays is preferred
Compensation & Benefits at insitro
Our target starting salary for successful US-based applicants for this role is $85,000 - $115,000. To determine starting pay, we consider multiple job-related factors including a candidate’s skills, education and experience, the level at which they are actually hired, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
- 401(k) plan with employer matching for contributions
- Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees), as well as mental health and well-being support
- Open, flexible vacation policy
- Paid parental leave
- Quarterly budget for books and online courses for self-development
- Support to occasionally attend professional conferences that are meaningful to your career growth and development
- New hire stipend for home office setup
- Monthly cell phone & internet stipend
- Access to free onsite baristas and cafe with daily lunch and breakfast
- Access to free onsite fitness center
- Commuter benefits
#LI-DH1
#LI-Onsite
About insitro
insitro is a data-driven drug discovery and development company using machine learning and data at scale to transform the way that drugs are discovered and developed for patients. insitro is developing predictive machine learning models to discover underlying biologic state based on human cohort data and in-house generated cellular data at scale. These predictive models can be brought to bear on key bottlenecks in pharmaceutical R&D to advance novel targets and patient biomarkers, design therapeutics, and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of biologic insights and molecules in neuroscience and metabolic diseases. Since formation in mid 2018, insitro has raised over $700 million from top tech, biotech, and crossover investors and from collaborations with pharmaceutical partners. For more information on insitro, please visit the company’s website at www.insitro.com .